Interventions to reduce fear of cancer recurrence could be cost effective and improve patients' quality of life. (Psycho-Oncology)
A novel cancer vaccine tailored to a patient's specific tumor stimulated an immune response in its first clinical test, a patient with advanced pancreatic cancer. (Washington University in St. Louis)
Janssen and Johnson & Johnson announced they will not pursue regulatory approval of the combination of apalutamide (Erleada) and abiraterone (Zytiga) plus prednisone for metastatic castration-resistant prostate cancer after evaluating results of the phase III ACIS trial.
Almost half of patients with previously treated genetically defined acute leukemias responded to the oral menin inhibitor SNDX-5613 in a phase I trial, Syndax announced.
A pilot study demonstrated the safety and feasibility of remote home monitoring for patients with cancer and COVID who do not require hospitalization. (Journal of Oncology Practice)
In a preclinical study simulating nerve damage caused by prostate cancer surgery, a drug initially developed to speed up wound healing induced regrowth and improved activity in nerves associated with erectile function. (Albert Einstein College of Medicine)
A liquid biopsy showed promise for identifying patients with colon cancer that has spread to lymph nodes. (City of Hope)
New insights into observations that Black men with prostate cancer live longer with immunotherapy than white men do. (Northwestern University Medical Center, Prostate Health Education Network)
Less-intensive management of breast cancer did not adversely affect disease recurrence or survival in older women. (UPMC Hillman Cancer Center, JAMA Network Open)
The introduction of immune checkpoint inhibitors developed in China could drive down the prices of immunotherapy drugs. (GlobalData)
"End of a Fantastic Voyage." Stephen A. Cannistra, MD, reflects on his 10 years as editor-in-chief of the Journal of Clinical Oncology.
![author['full_name']](https://clf1.medpagetoday.com/media/images/author/charlesBankhead_188.jpg)